GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (UKEX:PFE) » Definitions » E10

Pfizer (UKEX:PFE) E10 : ₴101.22 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Pfizer E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Pfizer's adjusted earnings per share data for the three months ended in Mar. 2024 was ₴22.050. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₴101.22 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Pfizer's average E10 Growth Rate was -10.40% per year. During the past 3 years, the average E10 Growth Rate was 8.30% per year. During the past 5 years, the average E10 Growth Rate was 9.20% per year. During the past 10 years, the average E10 Growth Rate was 5.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Pfizer was 20.10% per year. The lowest was -4.10% per year. And the median was 9.90% per year.

As of today (2024-05-26), Pfizer's current stock price is ₴1014.00. Pfizer's E10 for the quarter that ended in Mar. 2024 was ₴101.22. Pfizer's Shiller PE Ratio of today is 10.02.

During the past 13 years, the highest Shiller PE Ratio of Pfizer was 24.28. The lowest was 9.17. And the median was 17.42.


Pfizer E10 Historical Data

The historical data trend for Pfizer's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer E10 Chart

Pfizer Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 103.26

Pfizer Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 103.26 101.22

Competitive Comparison of Pfizer's E10

For the Drug Manufacturers - General subindustry, Pfizer's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pfizer's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pfizer's Shiller PE Ratio falls into.



Pfizer E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pfizer's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=22.05/131.7762*131.7762
=22.050

Current CPI (Mar. 2024) = 131.7762.

Pfizer Quarterly Data

per share eps CPI Adj_EPS
201406 18.041 100.560 23.641
201409 16.838 100.428 22.094
201412 7.617 99.070 10.132
201503 15.235 99.621 20.152
201506 16.838 100.684 22.038
201509 13.631 100.392 17.892
201512 -1.203 99.792 -1.589
201603 19.645 100.470 25.766
201606 13.230 101.688 17.145
201609 8.820 101.861 11.410
201612 5.212 101.863 6.743
201703 20.447 102.862 26.195
201706 20.447 103.349 26.071
201709 18.843 104.136 23.844
201712 80.984 104.011 102.602
201803 23.654 105.290 29.604
201806 26.059 106.317 32.299
201809 27.663 106.507 34.226
201812 -2.806 105.998 -3.488
201903 27.262 107.251 33.496
201906 35.681 108.070 43.508
201909 54.524 108.329 66.325
201912 -2.405 108.420 -2.923
202003 24.055 108.902 29.108
202006 24.857 108.767 30.115
202009 10.424 109.815 12.509
202012 4.009 109.897 4.807
202103 34.478 111.754 40.655
202106 39.289 114.631 45.165
202109 56.930 115.734 64.821
202112 23.654 117.630 26.499
202203 54.925 121.301 59.668
202206 69.358 125.017 73.108
202209 60.538 125.227 63.704
202212 34.879 125.222 36.705
202303 38.888 127.348 40.240
202306 16.437 128.729 16.826
202309 -16.838 129.860 -17.087
202312 -24.055 129.419 -24.493
202403 22.050 131.776 22.050

Add all the adjusted EPS together and divide 10 will get our e10.


Pfizer  (UKEX:PFE) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Pfizer's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=1014.00/101.22
=10.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Pfizer was 24.28. The lowest was 9.17. And the median was 17.42.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Pfizer E10 Related Terms

Thank you for viewing the detailed overview of Pfizer's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Pfizer (UKEX:PFE) Business Description

Address
66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.